4-(Trifluoromethoxy)phenylacetonitrile | CAS:49561-96-8

We serve 4-(Trifluoromethoxy)phenylacetonitrile CAS:49561-96-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-(Trifluoromethoxy)phenylacetonitrile

Chemical Name:4-(Trifluoromethoxy)phenylacetonitrile
CAS.NO:49561-96-8
Synonyms:4-(Trifluoromethoxy)phenylacetonitrile
2-(4-(Trifluoromethoxy)phenyl)acetonitrile
p-(Trifluoromethoxy)phenylacetonitrile
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Boiling Point 224.6±35.0 °C at 760 mmHg
Melting Point 30-33 °C(lit.)
Molecular Formula C9H6F3NO
Molecular Weight 201.145
Flash Point 89.6±25.9 °C
Vapour Pressure 0.1±0.4 mmHg at 25°C
Index of Refraction 1.461
 
Specification:
Appearance:White to yellow solid, or Colorless to yellow liquid
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 4-(Trifluoromethoxy)phenylacetonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,p-(Trifluoromethoxy)phenylacetonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(4-(Trifluoromethoxy)phenyl)acetonitrile Use and application,2-(4-(Trifluoromethoxy)phenyl)acetonitrile technical grade,usp/ep/jp grade.


Related News: The videos have gone viral on Chinese social media and have been praised as a novel way to raise awareness of the disease.4-Chlorophenylacetonitrile manufacturer Additional results from the trial with data on another goal of extending survival is expected in 2020, AstraZeneca said.2,5-Dibromo-3-nitropyridine supplier Established pharmaceutical companies have abandoned the original model of the entire industry chain, stripped R & D and production links through outsourcing, and shifted their focus to product layout and global operations.2,7-dibromotriphenylene vendor Established pharmaceutical companies have abandoned the original model of the entire industry chain, stripped R & D and production links through outsourcing, and shifted their focus to product layout and global operations.Established pharmaceutical companies have abandoned the original model of the entire industry chain, stripped R & D and production links through outsourcing, and shifted their focus to product layout and global operations.